Curi RMB Capital LLC lifted its stake in shares of Exponent, Inc. (NASDAQ:EXPO – Free Report) by 1.1% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 105,346 shares of the business services provider’s stock after purchasing an additional 1,157 shares during the period. Curi RMB Capital LLC owned 0.21% of Exponent worth $12,144,000 at the end of the most recent quarter.
Other large investors also recently made changes to their positions in the company. Quarry LP bought a new position in shares of Exponent during the 2nd quarter worth approximately $25,000. GAMMA Investing LLC boosted its position in Exponent by 67.7% during the second quarter. GAMMA Investing LLC now owns 379 shares of the business services provider’s stock worth $36,000 after purchasing an additional 153 shares during the period. Whittier Trust Co. of Nevada Inc. increased its holdings in shares of Exponent by 166.5% in the second quarter. Whittier Trust Co. of Nevada Inc. now owns 517 shares of the business services provider’s stock valued at $49,000 after purchasing an additional 323 shares during the last quarter. USA Financial Formulas bought a new position in shares of Exponent in the third quarter valued at about $60,000. Finally, Benjamin F. Edwards & Company Inc. lifted its stake in shares of Exponent by 70.5% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 873 shares of the business services provider’s stock worth $83,000 after buying an additional 361 shares during the last quarter. Institutional investors and hedge funds own 92.37% of the company’s stock.
Wall Street Analyst Weigh In
Separately, Truist Financial reissued a “buy” rating and issued a $120.00 price objective (up previously from $100.00) on shares of Exponent in a report on Friday, July 26th.
Insider Transactions at Exponent
In other Exponent news, Director Paul R. Johnston sold 14,000 shares of the stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $104.60, for a total value of $1,464,400.00. Following the completion of the sale, the director now owns 80,742 shares in the company, valued at approximately $8,445,613.20. This trade represents a 14.78 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Carol Lindstrom sold 1,039 shares of Exponent stock in a transaction on Monday, November 4th. The stock was sold at an average price of $96.32, for a total value of $100,076.48. Following the sale, the director now owns 5,871 shares in the company, valued at $565,494.72. The trade was a 15.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 22,039 shares of company stock valued at $2,291,286 in the last 90 days. 2.10% of the stock is currently owned by corporate insiders.
Exponent Stock Down 3.9 %
Shares of NASDAQ EXPO opened at $98.61 on Friday. The company has a market capitalization of $5.01 billion, a PE ratio of 47.64 and a beta of 0.69. The firm has a fifty day simple moving average of $107.33 and a 200 day simple moving average of $101.94. Exponent, Inc. has a twelve month low of $68.70 and a twelve month high of $115.75.
Exponent Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, December 20th. Shareholders of record on Friday, December 6th will be issued a $0.28 dividend. This represents a $1.12 dividend on an annualized basis and a yield of 1.14%. The ex-dividend date is Friday, December 6th. Exponent’s payout ratio is 54.11%.
About Exponent
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Stories
- Five stocks we like better than Exponent
- How Can Investors Benefit From After-Hours Trading
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- Want to Profit on the Downtrend? Downtrends, Explained.
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- What are earnings reports?
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.